ArticleAntioxidants (Basel, Switzerland)2021

Effects of a 12-Month Treatment with Glucagon-like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Oxidant and Antioxidant Biomarkers in Patients with Type 2 Diabetes.

Vaia Lambadiari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.